BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 23526388)

  • 1. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ethical reflections on cell reprogramming].
    Aznar Lucea J; Martínez M
    Cuad Bioet; 2012; 23(78):287-99. PubMed ID: 23130744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming of somatic cells.
    Rajasingh J
    Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming adult hematopoietic cells.
    Kaneko S; Otsu M; Nakauchi H
    Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors.
    Balasubramanian S; Babai N; Chaudhuri A; Qiu F; Bhattacharya S; Dave BJ; Parameswaran S; Carson SD; Thoreson WB; Sharp JG; Rao M; Ahmad I
    Stem Cells; 2009 Dec; 27(12):3053-62. PubMed ID: 19859985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical strategies for stem cell biology and regenerative medicine.
    Zhu S; Wei W; Ding S
    Annu Rev Biomed Eng; 2011 Aug; 13():73-90. PubMed ID: 21513460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro models of pancreatic differentiation using embryonic stem or induced pluripotent stem cells.
    Higuchi Y; Shiraki N; Kume S
    Congenit Anom (Kyoto); 2011 Mar; 51(1):21-5. PubMed ID: 21129040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
    Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
    Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will cell reprogramming resolve the embryonic stem cell controversy? A narrative review.
    Power C; Rasko JE
    Ann Intern Med; 2011 Jul; 155(2):114-21. PubMed ID: 21768585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonviral delivery for reprogramming to pluripotency and differentiation.
    Park HJ; Shin J; Kim J; Cho SW
    Arch Pharm Res; 2014 Jan; 37(1):107-19. PubMed ID: 24222505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stimulus-triggered acquisition of pluripotency: a new perspective in reprogramming of differentiated somatic cells].
    Blum HE
    Dtsch Med Wochenschr; 2014 Feb; 139(9):441-3. PubMed ID: 24557999
    [No Abstract]   [Full Text] [Related]  

  • 20. The ethics of stem cells revisited.
    de Miguel-Beriain I
    Adv Drug Deliv Rev; 2015 Mar; 82-83():176-80. PubMed ID: 25446134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.